Table 1. Demographic and clinical characteristics of participants.
| Characteristic |
T. whipplei- (n = 43) |
T. whipplei+ (n = 33) |
P-value* |
|---|---|---|---|
| Age, median year (IQR) | 53 (46–59) | 52 (46–58) | 0.87 |
| Female, sex, n (%) | 8 (19) | 16 (48) | 0.007 |
| CD4, median (IQR) | 616 (410–892) | 630 (379–876) | 0.89 |
| Viral load, median (IQR) copies per ml, | 109 (27–2478) | 102 (31–4965) | 0.85 |
| ART, n (%) | 41 (95) | 30 (91) | 0.65 |
| Prior pneumonia, n (%) | 9 (21%) | 5 (15%) | 0.57 |
| Smoker, n (%) | 24 (56) | 24 (73) | 0.16 |
| Cigarette pack year, median (IQR) | 3.2 (0–13.5) | 11.9 (0–21.8) | 0.23 |
| Post-FEV1/FVC<0.7, n (%) | 6 (15) | 6 (19) | 0.75 |
| DLco<0.8, n (%) | 26 (67) | 18 (58) | 0.62 |
IQR, interquartile range; ART, antiretroviral therapy.
* p values were calculated using t-test test for continuous variables and Fisher exact test for categorical.